Vermox is a prescription medicine used to treat infection symptoms caused by hookworm, roundworm, whipworm, and pinworm. The medicine is orally administered can be used for children and adults. The dosage of the tablet varies based on the infection caused by the above-listed worms.
MARKET SCOPE
The "Global Vermox Market Analysis to 2028" is a specialized and in-depth study of the food and beverages industry with a special focus on the global market trend analysis. The report aims to provide an overview of the vermox market with detailed market segmentation by form, distribution channel and geography. The report provides key statistics on the market status of the leading vermox market players and offers key trends and opportunities in the market.
MARKET SEGMENTATION
- Based on form, the global vermox market is segmented into oral suspension, and chewable tablets.
- Based on distribution channel, the market is bifurcated into hospital and retail pharmacies, and oline distribution.
Drivers-
- Increasing symptomps of worm among children below two years
- Growing production and FDA approvals for perdiatic medicines
- Rising symptoms of intestinal worms among adults
- Gorwing production of pharmaceutical products
- The stringent regulatory reforms may hinder the growth of market during the forecast period.
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides an overview and forecast of the global market based on various segments. It also provides market size and forecast estimates from the year 2019 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), the Middle East and Africa (MEA), and South America. The vermox market by each region is later sub-segmented by respective countries and segments. The report covers the analysis and forecast of 18 countries globally along with the current trend and opportunities prevailing in the region.
The report analyzes factors affecting the market from both demand and supply side and further evaluates market dynamics affecting the marketduring the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA, and South America after evaluating political, economic, social and technological factors affecting the vermox market in these regions.
IMPACT OF COVID-19 ON VERMOX MARKET
COVID-19 pandemic has affected the pharmaceutical industry to a great extent. The limited offline distribution channels have hindered the growth of various pharmaceutical segments, including Vermox. The widely affected regions by the poor distribution channels were the Middle East and Africa and South and Central America. However, the market has gained a good market value due to an increase in online distribution in the local areas and within the country.
MARKET PLAYERS
The report covers key developments in the vermox market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the marketwere acquisitions, and partnership & collaborations. These activities have paved way for the expansion of business and customer base of market players. The market payers from vermox market are anticipated to lucrative growth opportunities in the future with the rising demand for vermox in the global market.
The report also includes the profiles of key companies along with their SWOT analysis and market strategies in the vermox market. In addition, the report focuses on leading industry players with information such as company profiles, components, and services offered, financial information of the last 3 years, the key development in the past five years.
- Esteve Pharmaceuticals
- Amneal Pharmaceuticals, Inc.
- Johnson and Johnson
- Cadila Pharmaceuticals
- Tenry Pharmaceutical
- Eipico
- Physicians Total Care, Inc.
- Amedra Pharmaceuticals LLC
- Teva Pharmaceutical Industries Ltd.
- Bryant Ranch Prepack, Inc.